These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8091651

  • 1. The spread of a replication-competent MuLV retroviral vector can be efficiently blocked by deletion variants.
    Nouvel P, Panthier JJ, Condamine H.
    Virology; 1994 Oct; 204(1):180-9. PubMed ID: 8091651
    [Abstract] [Full Text] [Related]

  • 2. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
    Shuh M, Hill SA, Derse D.
    Virology; 1999 Sep 30; 262(2):442-51. PubMed ID: 10502522
    [Abstract] [Full Text] [Related]

  • 3. Comparisons of defective HTLV-I proviruses predict the mode of origin and coding potential of internally deleted genomes.
    Hill SA, Shuh M, Derse D.
    Virology; 1999 Oct 25; 263(2):273-81. PubMed ID: 10544101
    [Abstract] [Full Text] [Related]

  • 4. Virofection: a one-step procedure for using replication-defective retrovirus vectors.
    Flamant F, Samarut J.
    Virology; 1995 Aug 01; 211(1):234-40. PubMed ID: 7645216
    [Abstract] [Full Text] [Related]

  • 5. Defective retroviral endogenous RNA is efficiently transmitted by infectious particles produced on an avian retroviral vector packaging cell line.
    Ronfort C, Girod A, Cosset FL, Legras C, Nigon VM, Chebloune Y, Verdier G.
    Virology; 1995 Feb 20; 207(1):271-5. PubMed ID: 7871738
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
    Li M, Muller J, Xu F, Hearing VJ, Gorelik E.
    Cancer Res; 1996 Oct 01; 56(19):4464-74. PubMed ID: 8813142
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J, Moreno J, Sanchez-Perez L, Kottke T, Thompson J, Caruso M, Diaz RM, Vile R.
    Gene Ther; 2006 Oct 01; 13(20):1457-70. PubMed ID: 16724095
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
    Pechan PA, Herrlinger U, Aghi M, Jacobs A, Breakefield XO.
    J Gene Med; 1999 Oct 01; 1(3):176-85. PubMed ID: 10738566
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of the gag region on genome stability: avian retroviral vectors that contain sequences from the Bryan strain of Rous sarcoma virus.
    Federspiel MJ, Hughes SH.
    Virology; 1994 Sep 01; 203(2):211-20. PubMed ID: 8053145
    [Abstract] [Full Text] [Related]

  • 16. Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy.
    Chakraborty AK, Zink MA, Hodgson CP.
    Cancer Gene Ther; 1994 Jun 01; 1(2):113-8. PubMed ID: 7621242
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
    Chang LJ, Urlacher V, Iwakuma T, Cui Y, Zucali J.
    Gene Ther; 1999 May 01; 6(5):715-28. PubMed ID: 10505094
    [Abstract] [Full Text] [Related]

  • 18. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y, Sun S, Oparaocha I, Humeau L, Davis B, Cohen R, Binder G, Chang YN, Slepushkin V, Dropulic B.
    J Gene Med; 2005 Jun 01; 7(6):818-34. PubMed ID: 15693055
    [Abstract] [Full Text] [Related]

  • 19. Recombinant equine arteritis virus as an expression vector.
    de Vries AA, Glaser AL, Raamsman MJ, Rottier PJ.
    Virology; 2001 Jun 05; 284(2):259-76. PubMed ID: 11384225
    [Abstract] [Full Text] [Related]

  • 20. Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.
    Curran MA, Kaiser SM, Achacoso PL, Nolan GP.
    Mol Ther; 2000 Jan 05; 1(1):31-8. PubMed ID: 10933909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.